Clinical trial
Validation of Imaging-Based Biomarkers of Treatment Response in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide
NCT02677376 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of Imaging-Based Biomarkers of Treatment Response in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 27, 2016
- Completion date
- January 3, 2020
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.